SILDENAFIL CITRATE

SILDENAFIL CITRATE was reported 127803 times

SILDENAFIL CITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SEMEN VOLUME INCREASED 102 0.7286
1 ERECTION INCREASED 3025 0.7225
2 CYANOPSIA 373 0.6217
3 MALIGNANT MELANOMA STAGE II 77 0.4695
4 MALIGNANT MELANOMA STAGE III 77 0.3793
5 PULMONARY HYPERTENSIVE CRISIS 101 0.3727
6 DEVICE WIRELESS COMMUNICATION ISSUE 92 0.3552
7 CATHETER SITE PRURITUS 285 0.3246
8 MALIGNANT MELANOMA IN SITU 391 0.3156
9 CATHETER MANAGEMENT 279 0.3103
10 MALIGNANT MELANOMA STAGE I 83 0.3051
11 EJACULATION DISORDER 862 0.3036
12 PENIS DISORDER 708 0.2858
13 CATHETER SITE IRRITATION 95 0.2853
14 PAINFUL ERECTION 194 0.2816
15 PREMATURE EJACULATION 160 0.2481
16 CATHETER SITE RASH 111 0.2456
17 TRANSPLANT EVALUATION 123 0.2421
18 RIGHT VENTRICULAR FAILURE 1682 0.2398
19 PULMONARY ARTERIAL PRESSURE INCREASED 390 0.2393
20 CATHETER SITE DISCHARGE 268 0.2384
21 CATHETER SITE ERYTHEMA 496 0.2316
22 PULMONARY ARTERIAL HYPERTENSION 3330 0.2296
23 VENTILATION PERFUSION MISMATCH 64 0.2278
24 DEVICE MAINTENANCE ISSUE 130 0.2211
25 WALKING DISTANCE TEST ABNORMAL 85 0.2174
26 INFUSION SITE INFECTION 462 0.1986
27 PULMONARY VENO-OCCLUSIVE DISEASE 139 0.1986
28 OXYGEN CONSUMPTION INCREASED 432 0.1806
29 INFUSION SITE DISCHARGE 306 0.1744
30 CATHETER SITE SWELLING 159 0.1699
31 SPONTANEOUS PENILE ERECTION 104 0.1675
32 INFUSION SITE WARMTH 198 0.1615
33 INFUSION SITE IRRITATION 193 0.1502
34 INFUSION SITE OEDEMA 125 0.1495
35 PULMONARY HYPERTENSION 3037 0.1457
36 INFUSION SITE VESICLES 76 0.1445
37 OPTIC ISCHAEMIC NEUROPATHY 558 0.1440
38 INFUSION SITE CELLULITIS 76 0.1439
39 PENILE PAIN 435 0.1428
40 CATHETER SITE INFLAMMATION 80 0.1421
41 INFUSION SITE INDURATION 210 0.1416
42 CATHETER SITE PAIN 361 0.1390
43 INFUSION SITE HAEMORRHAGE 456 0.1385
44 INFUSION SITE PAIN 1751 0.1357
45 INFUSION SITE ERYTHEMA 1103 0.1307
46 LUNG TRANSPLANT 463 0.1306
47 RIGHT VENTRICULAR DILATATION 74 0.1278
48 PARACENTESIS 78 0.1268
49 PENILE SWELLING 153 0.1249
50 CHROMATOPSIA 94 0.1238
51 DEVICE ALARM ISSUE 222 0.1222
52 INFUSION SITE INFLAMMATION 85 0.1204
53 INFUSION SITE DISCOLOURATION 103 0.1170
54 PENILE HAEMORRHAGE 95 0.1164
55 DEVICE INFUSION ISSUE 283 0.1140
56 INFUSION SITE NODULE 107 0.1113
57 CATHETER SITE HAEMORRHAGE 273 0.1090
58 TESTICULAR DISORDER 109 0.1082
59 RIGHT VENTRICULAR DYSFUNCTION 117 0.1061
60 COR PULMONALE 101 0.1058
61 INFUSION SITE DISCOMFORT 108 0.1041
62 CATHETERISATION CARDIAC 462 0.1041
63 HEART TRANSPLANT 93 0.1028
64 CATHETER PLACEMENT 189 0.1018
65 CENTRAL VENOUS CATHETERISATION 304 0.1007
66 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 138 0.0982
67 INFUSION SITE SWELLING 616 0.0978
68 SUSPECTED COUNTERFEIT PRODUCT 380 0.0960
69 MALIGNANT MELANOMA 1280 0.0954
70 SCLERODERMA 341 0.0937
71 EJACULATION FAILURE 184 0.0916
72 INFUSION SITE RASH 125 0.0910
73 INFUSION SITE PRURITUS 276 0.0874
74 CATHETER SITE RELATED REACTION 65 0.0867
75 FLUID OVERLOAD 1188 0.0815
76 CHRONIC RESPIRATORY FAILURE 98 0.0811
77 CATHETER SITE INFECTION 306 0.0808
78 PAIN IN JAW 2212 0.0780
79 HEPATIC CONGESTION 72 0.0760
80 HYPERVOLAEMIA 367 0.0742
81 VASCULAR DEVICE INFECTION 320 0.0705
82 INFUSION SITE REACTION 204 0.0682
83 DEVICE RELATED SEPSIS 137 0.0680
84 DYSPNOEA AT REST 196 0.0676
85 FLUID RETENTION 3406 0.0669
86 BRAIN NATRIURETIC PEPTIDE INCREASED 202 0.0655
87 CARBON DIOXIDE INCREASED 89 0.0652
88 PRIAPISM 224 0.0649
89 DYSPNOEA EXERTIONAL 2339 0.0620
90 TESTICULAR SWELLING 74 0.0585
91 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62 0.0584
92 ERECTILE DYSFUNCTION 1497 0.0582
93 DEVICE RELATED INFECTION 888 0.0576
94 TRANSFUSION 598 0.0570
95 DERMATITIS CONTACT 632 0.0554
96 CARDIOVERSION 76 0.0544
97 DEVICE CONNECTION ISSUE 113 0.0535
98 METASTATIC MALIGNANT MELANOMA 119 0.0517
99 PACKED RED BLOOD CELL TRANSFUSION 68 0.0514
100 OXYGEN SATURATION ABNORMAL 143 0.0503
101 NOCTURNAL DYSPNOEA 64 0.0502
102 ANORGASMIA 134 0.0493
103 MECHANICAL VENTILATION 93 0.0489
104 OXYGEN THERAPY 80 0.0486
105 CARDIAC ABLATION 85 0.0475
106 EXERCISE TOLERANCE DECREASED 272 0.0472
107 OXYGEN SATURATION DECREASED 2629 0.0467
108 SEASONAL ALLERGY 658 0.0464
109 CHORIORETINOPATHY 65 0.0456
110 TRACHEOSTOMY 64 0.0448
111 ATRIAL TACHYCARDIA 94 0.0447
112 HAEMOGLOBIN INCREASED 197 0.0431
113 THROMBOSIS IN DEVICE 141 0.0430
114 ECHOCARDIOGRAM ABNORMAL 59 0.0421
115 PURULENT DISCHARGE 171 0.0400
116 RHINOVIRUS INFECTION 155 0.0398
117 INFUSION SITE BRUISING 86 0.0398
118 HYPOXIA 1398 0.0397
119 SUBSTANCE USE DISORDER 125 0.0392
120 RETINAL VEIN OCCLUSION 110 0.0382
121 NASAL CONGESTION 2232 0.0379
122 CONCOMITANT DISEASE AGGRAVATED 233 0.0377
123 ORTHOPNOEA 120 0.0376
124 NEPHROGENIC ANAEMIA 167 0.0360
125 PRODUCT COUNTERFEIT 62 0.0359
126 CONCOMITANT DISEASE PROGRESSION 70 0.0358
127 PRE-EXISTING CONDITION IMPROVED 220 0.0352
128 HYPERPARATHYROIDISM SECONDARY 88 0.0351
129 DEVICE POWER SOURCE ISSUE 102 0.0349
130 ACUTE RESPIRATORY FAILURE 669 0.0347
131 OEDEMA 1877 0.0346
132 VASODILATATION 87 0.0345
133 DRUG EFFECT DELAYED 156 0.0344
134 PRURITUS GENITAL 80 0.0339
135 ATRIAL FLUTTER 270 0.0338
136 LEFT VENTRICULAR FAILURE 113 0.0328
137 LOCALISED OEDEMA 149 0.0322
138 LIVER TRANSPLANT 116 0.0319
139 ENDOTRACHEAL INTUBATION 88 0.0314
140 INJECTION SITE INFECTION 102 0.0310
141 CARDIAC FAILURE ACUTE 206 0.0309
142 ACTINIC KERATOSIS 78 0.0300
143 RALES 174 0.0299
144 CARDIAC OPERATION 255 0.0296
145 STAPHYLOCOCCUS TEST POSITIVE 62 0.0294
146 DIZZINESS POSTURAL 284 0.0293
147 DEVICE OCCLUSION 410 0.0291
148 BLOOD CULTURE POSITIVE 86 0.0287
149 DRUG TOLERANCE DECREASED 80 0.0285
150 RESPIRATION ABNORMAL 196 0.0284
151 PULMONARY PAIN 83 0.0284
152 PERICARDIAL EFFUSION 657 0.0284
153 RETINAL ARTERY OCCLUSION 71 0.0281
154 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 172 0.0278
155 PULMONARY OEDEMA 1240 0.0277
156 FLUSHING 2807 0.0276
157 DEAFNESS UNILATERAL 152 0.0276
158 INJECTION SITE DISCHARGE 147 0.0273
159 DRUG TITRATION ERROR 70 0.0271
160 TESTICULAR PAIN 85 0.0268
161 CARDIAC FAILURE CHRONIC 114 0.0267
162 VISUAL FIELD DEFECT 192 0.0265
163 CARDIAC PACEMAKER INSERTION 157 0.0263
164 RESPIRATORY TRACT INFECTION VIRAL 61 0.0262
165 PROSTATIC DISORDER 144 0.0261
166 HYPERCAPNIA 78 0.0259
167 BLOOD PRESSURE SYSTOLIC DECREASED 117 0.0257
168 TRANSPLANT 61 0.0257
169 HERNIA REPAIR 63 0.0242
170 SINUS CONGESTION 327 0.0242
171 CARDIAC FAILURE 1941 0.0242
172 COMPLICATION ASSOCIATED WITH DEVICE 350 0.0241
173 ASCITES 702 0.0239
174 DRUG EFFECT INCOMPLETE 866 0.0238
175 REBOUND ACID HYPERSECRETION 72 0.0238
176 PARANASAL SINUS DISCOMFORT 90 0.0238
177 DYSPNOEA 13449 0.0237
178 DEAFNESS NEUROSENSORY 78 0.0237
179 THERAPY NON-RESPONDER 1066 0.0237
180 SYNCOPE 2372 0.0237
181 HAEMOPTYSIS 661 0.0237
182 TRICUSPID VALVE INCOMPETENCE 188 0.0236
183 PRESYNCOPE 575 0.0236
184 PARANASAL SINUS HYPERSECRETION 89 0.0233
185 CYANOSIS 364 0.0231
186 EMERGENCY CARE 70 0.0231
187 BLOOD TESTOSTERONE DECREASED 157 0.0229
188 OEDEMA PERIPHERAL 2766 0.0227
189 DISEASE COMPLICATION 103 0.0225
190 PROSTATOMEGALY 88 0.0224
191 BENIGN PROSTATIC HYPERPLASIA 115 0.0222
192 CARDIOMEGALY 273 0.0222
193 CARDIAC FAILURE CONGESTIVE 1774 0.0221
194 PRODUCTIVE COUGH 1053 0.0220
195 PRODUCT ADMINISTRATION INTERRUPTED 173 0.0220
196 DIALYSIS 312 0.0220
197 RESPIRATORY FAILURE 1603 0.0220
198 THERAPY CHANGE 216 0.0219
199 BLINDNESS UNILATERAL 307 0.0217
200 PULMONARY HAEMORRHAGE 168 0.0215
201 CHOKING SENSATION 117 0.0212
202 GOUT 378 0.0210
203 RESPIRATORY SYNCYTIAL VIRUS INFECTION 183 0.0210
204 EPISTAXIS 1552 0.0207
205 PULSELESS ELECTRICAL ACTIVITY 86 0.0206
206 SELF-MEDICATION 84 0.0204
207 HEARING IMPAIRED 119 0.0198
208 CAROTID ARTERY OCCLUSION 72 0.0197
209 SINUS DISORDER 388 0.0196
210 CARDIOPULMONARY FAILURE 76 0.0195
211 PULMONARY CONGESTION 256 0.0194
212 SUDDEN CARDIAC DEATH 66 0.0193
213 END STAGE RENAL DISEASE 352 0.0193
214 AMMONIA INCREASED 98 0.0192
215 VISUAL DISTURBANCE 110 0.0192
216 HYPOTENSION 3837 0.0191
217 TENSION HEADACHE 81 0.0188
218 EXPIRED DRUG ADMINISTERED 93 0.0188
219 IRON DEFICIENCY ANAEMIA 173 0.0187
220 NASAL DRYNESS 116 0.0185
221 SUDDEN DEATH 195 0.0184
222 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 957 0.0183
223 TERMINAL STATE 122 0.0182
224 BLOOD IRON DECREASED 215 0.0181
225 VIRAL UPPER RESPIRATORY TRACT INFECTION 86 0.0181
226 CHEST PAIN 3339 0.0180
227 RESPIRATORY TRACT CONGESTION 283 0.0178
228 LUNG DISORDER 872 0.0178
229 MACULOPATHY 63 0.0177
230 BLOOD PRESSURE DECREASED 1178 0.0177
231 SPUTUM DISCOLOURED 167 0.0176
232 CARDIOGENIC SHOCK 251 0.0175
233 COUGH 4876 0.0174
234 INTERNAL HAEMORRHAGE 198 0.0173
235 MEDICAL DEVICE COMPLICATION 128 0.0173
236 SARCOIDOSIS 82 0.0172
237 IDIOPATHIC PULMONARY FIBROSIS 68 0.0172
238 CARDIAC FLUTTER 111 0.0172
239 THROAT IRRITATION 766 0.0171
240 AORTIC STENOSIS 59 0.0169
241 STENT PLACEMENT 134 0.0166
242 RESPIRATORY DISTRESS 458 0.0166
243 GENERALISED OEDEMA 205 0.0165
244 HEADACHE 10379 0.0165
245 BLINDNESS TRANSIENT 120 0.0163
246 DEVICE DISLOCATION 701 0.0161
247 PALPITATIONS 1874 0.0160
248 BLINDNESS 652 0.0160
249 CHEST DISCOMFORT 1636 0.0160
250 CARDIAC VALVE DISEASE 91 0.0159
251 INTERNATIONAL NORMALISED RATIO DECREASED 64 0.0158
252 FACE INJURY 60 0.0158
253 SUPRAVENTRICULAR TACHYCARDIA 149 0.0155
254 DEAFNESS 406 0.0155
255 SKIN ODOUR ABNORMAL 61 0.0155
256 PHOTOPSIA 98 0.0155
257 PNEUMONIA 5007 0.0154
258 HEART RATE ABNORMAL 86 0.0154
259 BLOOD POTASSIUM DECREASED 462 0.0153
260 DEVICE FAILURE 233 0.0153
261 DECREASED ACTIVITY 165 0.0153
262 INFUSION SITE EXTRAVASATION 95 0.0152
263 BREATH SOUNDS ABNORMAL 75 0.0152
264 EAR DISCOMFORT 156 0.0152
265 PNEUMOTHORAX 241 0.0152
266 SLEEP APNOEA SYNDROME 290 0.0152
267 HAEMORRHOIDAL HAEMORRHAGE 74 0.0151
268 FACIAL PAIN 135 0.0151
269 POOR PERIPHERAL CIRCULATION 64 0.0150
270 BACTERAEMIA 178 0.0150
271 STAPHYLOCOCCAL BACTERAEMIA 65 0.0149
272 PULMONARY THROMBOSIS 163 0.0149
273 SUBARACHNOID HAEMORRHAGE 152 0.0149
274 SECRETION DISCHARGE 186 0.0148
275 HAEMODYNAMIC INSTABILITY 113 0.0148
276 BLOOD PRESSURE ABNORMAL 292 0.0147
277 HEART RATE INCREASED 1450 0.0146
278 PERIPHERAL SWELLING 2234 0.0145
279 LEFT VENTRICULAR HYPERTROPHY 62 0.0145
280 PLEURAL EFFUSION 880 0.0144
281 PULMONARY ALVEOLAR HAEMORRHAGE 81 0.0144
282 LIVER FUNCTION TEST ABNORMAL 419 0.0144
283 ONYCHOMYCOSIS 63 0.0143
284 WEIGHT FLUCTUATION 150 0.0143
285 INCORRECT DRUG ADMINISTRATION RATE 61 0.0143
286 PULMONARY FIBROSIS 274 0.0143
287 PRODUCT LEAKAGE 80 0.0142
288 ATRIAL FIBRILLATION 1385 0.0142
289 PREMATURE DELIVERY 226 0.0142
290 RHINITIS ALLERGIC 63 0.0141
291 CARDIAC DISORDER 1321 0.0141
292 GASTROENTERITIS VIRAL 254 0.0141
293 VIRAL INFECTION 466 0.0140
294 MUSCLE STRAIN 121 0.0140
295 DIABETIC NEUROPATHY 69 0.0139
296 SINUS HEADACHE 82 0.0138
297 HEAD DISCOMFORT 244 0.0138
298 ATELECTASIS 133 0.0138
299 PAPILLOEDEMA 62 0.0137
300 LOCALISED INFECTION 332 0.0137
301 CELLULITIS 691 0.0137
302 ECONOMIC PROBLEM 207 0.0136
303 FLANK PAIN 128 0.0136
304 UPPER RESPIRATORY TRACT INFECTION 623 0.0135
305 UNEVALUABLE EVENT 1015 0.0134
306 HEPATIC CIRRHOSIS 252 0.0134
307 HEART RATE IRREGULAR 303 0.0134
308 HEAD INJURY 420 0.0133
309 BACK INJURY 143 0.0131
310 CORONARY ARTERY STENOSIS 66 0.0131
311 MITRAL VALVE INCOMPETENCE 146 0.0129
312 COMPRESSION FRACTURE 69 0.0129
313 CARDIAC TAMPONADE 61 0.0128
314 VENTRICULAR TACHYCARDIA 211 0.0128
315 RETCHING 272 0.0127
316 CHRONIC KIDNEY DISEASE 963 0.0127
317 CIRCULATORY COLLAPSE 215 0.0126
318 TROPONIN INCREASED 95 0.0125
319 DRY THROAT 126 0.0124
320 FAECES SOFT 90 0.0124
321 MULTIPLE ALLERGIES 97 0.0124
322 HOSPICE CARE 122 0.0123
323 HYPOVOLAEMIA 72 0.0123
324 HAEMATOCRIT DECREASED 243 0.0122
325 BLOOD BILIRUBIN INCREASED 330 0.0122
326 BLOOD ALKALINE PHOSPHATASE INCREASED 303 0.0122
327 RHINORRHOEA 785 0.0121
328 BRONCHITIS 893 0.0121
329 RESPIRATORY DISORDER 360 0.0120
330 PHOTOPHOBIA 225 0.0120
331 RENAL FAILURE 1588 0.0119
332 DIZZINESS 5957 0.0119
333 SEXUAL DYSFUNCTION 140 0.0119
334 ARTERIOSCLEROSIS CORONARY ARTERY 79 0.0119
335 UPPER-AIRWAY COUGH SYNDROME 98 0.0119
336 ENDOCARDITIS 61 0.0119
337 DEVICE PHYSICAL PROPERTY ISSUE 91 0.0119
338 EMPHYSEMA 119 0.0118
339 URINE OUTPUT DECREASED 103 0.0118
340 SKIN INFECTION 132 0.0118
341 NASOPHARYNGITIS 2165 0.0117
342 MUSCULOSKELETAL CHEST PAIN 181 0.0117
343 PNEUMONIA BACTERIAL 107 0.0116
344 DYSLIPIDAEMIA 59 0.0116
345 CLOSTRIDIUM DIFFICILE INFECTION 253 0.0116
346 VISUAL ACUITY REDUCED 385 0.0116
347 HEPATOMEGALY 113 0.0115
348 HYPOACUSIS 494 0.0115
349 INFLUENZA 1274 0.0114
350 SKIN LACERATION 124 0.0114
351 RETINAL HAEMORRHAGE 81 0.0114
352 LIGAMENT SPRAIN 112 0.0113
353 HYPERLIPIDAEMIA 135 0.0113
354 ACUTE PULMONARY OEDEMA 63 0.0112
355 CARDIAC MURMUR 97 0.0112
356 ABDOMINAL DISTENSION 1166 0.0112
357 CARDIAC ARREST 921 0.0111
358 SWELLING 1041 0.0111
359 POLYURIA 91 0.0111
360 SKIN ULCER 287 0.0111
361 DIARRHOEA 7160 0.0111
362 CORONARY ARTERY OCCLUSION 152 0.0111
363 HOSPITALISATION 1703 0.0111
364 PREMATURE BABY 333 0.0111
365 RESPIRATORY TRACT INFECTION 288 0.0110
366 RIB FRACTURE 227 0.0110
367 LUNG INFECTION 171 0.0110
368 CATARACT OPERATION 65 0.0109
369 ARTHROPOD BITE 81 0.0109
370 RENAL FAILURE CHRONIC 84 0.0109
371 GASTROINTESTINAL HAEMORRHAGE 913 0.0109
372 LOSS OF CONSCIOUSNESS 1396 0.0109
373 OROPHARYNGEAL DISCOMFORT 98 0.0108
374 SUBDURAL HAEMATOMA 155 0.0108
375 OROPHARYNGEAL PAIN 1001 0.0108
376 RESPIRATORY RATE INCREASED 96 0.0108
377 CORONARY ARTERY DISEASE 326 0.0108
378 HIP FRACTURE 346 0.0107
379 NASAL DISCOMFORT 85 0.0107
380 EYE HAEMORRHAGE 143 0.0107
381 RENAL DISORDER 499 0.0107
382 BACK DISORDER 174 0.0107
383 LARGE INTESTINE POLYP 74 0.0107
384 BLOOD MAGNESIUM DECREASED 92 0.0106
385 DEATH 9183 0.0106
386 CONDITION AGGRAVATED 3236 0.0106
387 DRUG EFFECT DECREASED 573 0.0106
388 DISEASE PROGRESSION 1254 0.0106
389 PAIN IN EXTREMITY 3117 0.0106
390 SEPSIS 1179 0.0106
391 DYSPEPSIA 1038 0.0105
392 SQUAMOUS CELL CARCINOMA 99 0.0105
393 ELECTROLYTE IMBALANCE 122 0.0105
394 SLUGGISHNESS 107 0.0105
395 DEVICE LEAKAGE 454 0.0105
396 INTERNATIONAL NORMALISED RATIO INCREASED 298 0.0104
397 POST-TRAUMATIC STRESS DISORDER 70 0.0104
398 ARTERIAL OCCLUSIVE DISEASE 82 0.0104
399 LACERATION 98 0.0104
400 ASPARTATE AMINOTRANSFERASE INCREASED 551 0.0104
401 ANHEDONIA 272 0.0103
402 ABDOMINAL DISCOMFORT 1729 0.0103
403 MALAISE 4517 0.0103
404 STAPHYLOCOCCAL INFECTION 339 0.0103
405 PELVIC FRACTURE 80 0.0103
406 TINNITUS 471 0.0102
407 BLOOD POTASSIUM INCREASED 165 0.0102
408 LIMB INJURY 274 0.0101
409 GASTROOESOPHAGEAL REFLUX DISEASE 804 0.0100
410 BACTERIAL INFECTION 186 0.0100
411 HEPATIC ENCEPHALOPATHY 93 0.0100
412 HERNIA 192 0.0099
413 HEART RATE DECREASED 348 0.0099
414 VENTRICULAR FIBRILLATION 110 0.0099
415 HAEMOGLOBIN DECREASED 1016 0.0099
416 MYALGIA 1681 0.0099
417 ACUTE MYOCARDIAL INFARCTION 291 0.0099
418 DYSURIA 363 0.0099
419 HOT FLUSH 743 0.0098
420 RESTLESS LEGS SYNDROME 179 0.0098
421 POST PROCEDURAL COMPLICATION 189 0.0098
422 WEIGHT DECREASED 2745 0.0098
423 SPINAL FRACTURE 197 0.0098
424 DRUG INEFFECTIVE 12827 0.0097
425 LEFT VENTRICULAR DYSFUNCTION 65 0.0097
426 ABNORMAL LOSS OF WEIGHT 66 0.0097
427 TREATMENT NONCOMPLIANCE 529 0.0097
428 INTENTIONAL PRODUCT MISUSE 842 0.0096
429 RETINAL DETACHMENT 88 0.0096
430 BLOOD UREA INCREASED 160 0.0095
431 BLOOD SODIUM DECREASED 180 0.0095
432 MENTAL STATUS CHANGES 265 0.0095
433 ANAEMIA 1818 0.0095
434 BEDRIDDEN 125 0.0095
435 LOWER GASTROINTESTINAL HAEMORRHAGE 70 0.0095
436 ARRHYTHMIA 448 0.0095
437 FALL 3148 0.0094
438 ALANINE AMINOTRANSFERASE INCREASED 580 0.0094
439 DEHYDRATION 1260 0.0094
440 PROCEDURAL COMPLICATION 72 0.0094
441 LOWER LIMB FRACTURE 180 0.0094
442 NECK PAIN 523 0.0093
443 GLAUCOMA 180 0.0093
444 LOSS OF LIBIDO 84 0.0093
445 TRANSIENT ISCHAEMIC ATTACK 314 0.0093
446 MACULAR DEGENERATION 111 0.0093
447 MOUTH HAEMORRHAGE 68 0.0093
448 NO THERAPEUTIC RESPONSE 113 0.0093
449 BODY HEIGHT DECREASED 99 0.0092
450 MUSCULOSKELETAL DISCOMFORT 159 0.0092
451 DECREASED APPETITE 2145 0.0092
452 VISION BLURRED 1268 0.0092
453 THERAPEUTIC RESPONSE UNEXPECTED 414 0.0092
454 APPETITE DISORDER 61 0.0092
455 PRODUCT USE ISSUE 1729 0.0092
456 ELECTROCARDIOGRAM ABNORMAL 72 0.0092
457 FEELING HOT 562 0.0092
458 CARDIO-RESPIRATORY ARREST 381 0.0091
459 DIABETES MELLITUS 694 0.0091
460 PERIPHERAL COLDNESS 125 0.0091
461 BASAL CELL CARCINOMA 142 0.0091
462 HAEMATEMESIS 230 0.0091
463 ACCIDENT 108 0.0090
464 BLOOD COUNT ABNORMAL 137 0.0090
465 JOINT INJURY 193 0.0090
466 TOOTH ABSCESS 92 0.0090
467 UPPER LIMB FRACTURE 180 0.0090
468 HYPERSOMNIA 259 0.0090
469 LIVER FUNCTION TEST INCREASED 193 0.0090
470 ROAD TRAFFIC ACCIDENT 376 0.0090
471 BLOOD DISORDER 72 0.0090
472 NEUTROPHIL COUNT INCREASED 92 0.0090
473 ANKLE FRACTURE 139 0.0090
474 ROTATOR CUFF SYNDROME 115 0.0089
475 ASPIRATION 98 0.0089
476 FAECES DISCOLOURED 194 0.0089
477 POST PROCEDURAL HAEMORRHAGE 104 0.0089
478 SNEEZING 200 0.0089
479 GALLBLADDER DISORDER 159 0.0089
480 WHEEZING 526 0.0089
481 ULCER HAEMORRHAGE 60 0.0089
482 INTERVERTEBRAL DISC DEGENERATION 82 0.0089
483 JOINT EFFUSION 61 0.0088
484 FEELING ABNORMAL 2117 0.0088
485 LOW BIRTH WEIGHT BABY 70 0.0088
486 THERAPY PARTIAL RESPONDER 137 0.0088
487 POOR QUALITY SLEEP 189 0.0088
488 HAEMORRHOIDS 171 0.0088
489 ORAL CANDIDIASIS 115 0.0087
490 EAR INFECTION 232 0.0087
491 BACK PAIN 2021 0.0087
492 MYOCARDIAL ISCHAEMIA 99 0.0087
493 HAEMODIALYSIS 73 0.0087
494 PRODUCT DOSE OMISSION 566 0.0087
495 SKIN DISCOLOURATION 398 0.0087
496 CARDIOMYOPATHY 128 0.0087
497 LIVER DISORDER 384 0.0087
498 ANGINA PECTORIS 248 0.0086
499 TACHYCARDIA 761 0.0086
500 RENAL CYST 68 0.0086
501 MULTI-ORGAN FAILURE 148 0.0086
502 GROIN PAIN 75 0.0085
503 PRESCRIBED OVERDOSE 165 0.0085
504 TOOTH INFECTION 112 0.0085
505 CLOSTRIDIUM DIFFICILE COLITIS 90 0.0085
506 WEIGHT INCREASED 1897 0.0085
507 RECTAL HAEMORRHAGE 361 0.0084
508 TOOTHACHE 152 0.0084
509 COLON CANCER 125 0.0084
510 BRONCHOSPASM 119 0.0083
511 FATIGUE 6493 0.0083
512 ACUTE KIDNEY INJURY 1276 0.0083
513 ANAL INCONTINENCE 75 0.0083
514 ASPHYXIA 68 0.0083
515 POLLAKIURIA 347 0.0083
516 MELAENA 183 0.0083
517 NAUSEA 6580 0.0083
518 OSTEOPENIA 126 0.0083
519 DRUG INTOLERANCE 802 0.0083
520 MUSCULOSKELETAL PAIN 434 0.0083
521 AORTIC ANEURYSM 63 0.0083
522 GASTRIC DISORDER 284 0.0083
523 NERVE INJURY 92 0.0083
524 LUNG INFILTRATION 73 0.0083
525 PULMONARY MASS 123 0.0082
526 GASTRIC HAEMORRHAGE 95 0.0082
527 VISUAL IMPAIRMENT 1023 0.0082
528 ASTHENIA 3099 0.0082
529 VITREOUS FLOATERS 81 0.0082
530 NERVE COMPRESSION 76 0.0082
531 SMALL INTESTINAL OBSTRUCTION 101 0.0082
532 COAGULOPATHY 136 0.0082
533 FEELING COLD 227 0.0081
534 VOMITING 3832 0.0081
535 UPPER GASTROINTESTINAL HAEMORRHAGE 137 0.0081
536 NEPHROPATHY 76 0.0081
537 SEPTIC SHOCK 354 0.0081
538 OBESITY 129 0.0081
539 BLOOD URINE PRESENT 153 0.0081
540 PALLOR 219 0.0080
541 DIVERTICULITIS 223 0.0080
542 THERAPY CESSATION 413 0.0080
543 FLATULENCE 456 0.0080
544 FOOT FRACTURE 152 0.0080
545 LIMB DISCOMFORT 248 0.0080
546 CONCUSSION 62 0.0080
547 DIPLOPIA 207 0.0080
548 INTERSTITIAL LUNG DISEASE 384 0.0079
549 MIGRAINE 757 0.0079
550 SINUSITIS 808 0.0079
551 SPINAL OSTEOARTHRITIS 69 0.0078
552 SCIATICA 125 0.0078
553 INTERVERTEBRAL DISC PROTRUSION 171 0.0078
554 HIATUS HERNIA 101 0.0078
555 UNRESPONSIVE TO STIMULI 201 0.0078
556 MYOPATHY 67 0.0077
557 OBSESSIVE-COMPULSIVE DISORDER 62 0.0077
558 CHOLECYSTECTOMY 88 0.0077
559 KIDNEY INFECTION 151 0.0077
560 TENDERNESS 80 0.0077
561 RENAL TUBULAR NECROSIS 75 0.0076
562 ABDOMINAL PAIN UPPER 1570 0.0076
563 INTENTIONAL PRODUCT USE ISSUE 668 0.0076
564 SPINAL COMPRESSION FRACTURE 63 0.0076
565 DRUG INTERACTION 1208 0.0076
566 BLOOD CREATININE INCREASED 497 0.0076
567 MALNUTRITION 85 0.0076
568 BRAIN INJURY 76 0.0076
569 SINUS TACHYCARDIA 107 0.0075
570 SYSTEMIC LUPUS ERYTHEMATOSUS 267 0.0075
571 RED BLOOD CELL COUNT DECREASED 215 0.0075
572 TACHYPNOEA 102 0.0075
573 MYOCARDIAL INFARCTION 1303 0.0075
574 GASTROENTERITIS 109 0.0075
575 BLOOD CHOLESTEROL INCREASED 347 0.0074
576 HAEMORRHAGE 777 0.0074
577 FRUSTRATION TOLERANCE DECREASED 60 0.0074
578 GASTROINTESTINAL DISORDER 664 0.0074
579 HIP ARTHROPLASTY 113 0.0074
580 CEREBRAL HAEMORRHAGE 264 0.0074
581 LETHARGY 424 0.0074
582 HYPOKALAEMIA 340 0.0074
583 FEELING JITTERY 140 0.0073
584 ARTERIOSCLEROSIS 69 0.0073
585 HYPERTHYROIDISM 106 0.0073
586 HYPERTENSION 1550 0.0073
587 EAR PAIN 142 0.0073
588 ORTHOSTATIC HYPOTENSION 127 0.0073
589 ULCER 116 0.0073
590 CATARACT 434 0.0073
591 ISCHAEMIC STROKE 130 0.0073
592 EYE DISORDER 239 0.0073
593 PROSTATIC SPECIFIC ANTIGEN INCREASED 100 0.0073
594 DYSPHONIA 424 0.0072
595 CHOKING 141 0.0072
596 INTENTIONAL DRUG MISUSE 151 0.0072
597 RESPIRATORY ARREST 199 0.0072
598 THROMBOSIS 580 0.0072
599 INFECTION 1043 0.0072
600 BRAIN FOG 112 0.0071
601 CHOLECYSTITIS 85 0.0071
602 COVID-19 PNEUMONIA 84 0.0071
603 ANXIETY 2024 0.0071
604 HEPATIC FAILURE 214 0.0071
605 COLD SWEAT 125 0.0071
606 WRIST FRACTURE 85 0.0071
607 NOCTURIA 86 0.0071
608 HAEMATOCHEZIA 390 0.0071
609 OCULAR DISCOMFORT 79 0.0070
610 UNINTENTIONAL MEDICAL DEVICE REMOVAL 81 0.0070
611 CHILLS 819 0.0070
612 INTENTIONAL DOSE OMISSION 199 0.0070
613 TEMPERATURE INTOLERANCE 72 0.0070
614 AUTOIMMUNE DISORDER 68 0.0070
615 RENAL FAILURE ACUTE 296 0.0070
616 ANURIA 60 0.0070
617 IMPAIRED GASTRIC EMPTYING 95 0.0070
618 NEURALGIA 169 0.0069
619 HYSTERECTOMY 60 0.0069
620 EXPIRED PRODUCT ADMINISTERED 230 0.0069
621 EYE INFECTION 78 0.0069
622 CHOLELITHIASIS 226 0.0069
623 PNEUMONIA ASPIRATION 172 0.0069
624 APHONIA 96 0.0069
625 BLOOD PRESSURE FLUCTUATION 165 0.0069
626 URINARY TRACT INFECTION 1172 0.0069
627 SPLENOMEGALY 80 0.0068
628 GENERAL PHYSICAL HEALTH DETERIORATION 789 0.0068
629 DRY MOUTH 553 0.0068
630 KNEE OPERATION 67 0.0068
631 GASTROINTESTINAL INFECTION 61 0.0068
632 BRADYCARDIA 360 0.0068
633 CYSTITIS 216 0.0068
634 PYREXIA 2338 0.0067
635 HAEMATOMA 175 0.0067
636 THIRST 120 0.0067
637 PETECHIAE 70 0.0067
638 MULTIPLE ORGAN DYSFUNCTION SYNDROME 190 0.0067
639 CEREBROVASCULAR ACCIDENT 1132 0.0067
640 SWELLING FACE 435 0.0067
641 DEVICE ISSUE 598 0.0067
642 MUSCLE TIGHTNESS 108 0.0067
643 PHARYNGITIS STREPTOCOCCAL 72 0.0066
644 GASTRITIS 175 0.0066
645 VASCULITIS 77 0.0066
646 RENAL INJURY 196 0.0066
647 LACRIMATION INCREASED 199 0.0066
648 FACE OEDEMA 111 0.0066
649 OCULAR HYPERAEMIA 311 0.0065
650 DIABETES MELLITUS INADEQUATE CONTROL 116 0.0065
651 INSOMNIA 1739 0.0065
652 DRUG DOSE OMISSION 1078 0.0065
653 TUBULOINTERSTITIAL NEPHRITIS 122 0.0065
654 GAMMA-GLUTAMYLTRANSFERASE INCREASED 144 0.0065
655 HEMIPARESIS 110 0.0065
656 PROSTATE CANCER 517 0.0064
657 BODY TEMPERATURE INCREASED 131 0.0064
658 RENAL IMPAIRMENT 539 0.0064
659 INCREASED TENDENCY TO BRUISE 59 0.0064
660 MUSCLE SPASMS 1168 0.0064
661 SPINAL DISORDER 60 0.0063
662 CONTUSION 609 0.0063
663 JAUNDICE 169 0.0063
664 FEEDING DISORDER 127 0.0063
665 SHOCK 144 0.0063
666 VENTRICULAR EXTRASYSTOLES 65 0.0063
667 INCONTINENCE 66 0.0062
668 ILLNESS 643 0.0062
669 NEPHROLITHIASIS 286 0.0062
670 PAIN 3823 0.0062
671 ACUTE RESPIRATORY DISTRESS SYNDROME 110 0.0062
672 PHARYNGITIS 77 0.0062
673 OSTEOPOROSIS 255 0.0062
674 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 340 0.0062
675 NERVOUSNESS 323 0.0062
676 HYPERHIDROSIS 795 0.0062
677 INTESTINAL OBSTRUCTION 232 0.0061
678 VITAMIN D DEFICIENCY 60 0.0061
679 ANOSMIA 89 0.0061
680 LOCAL SWELLING 107 0.0061
681 CHROMATURIA 138 0.0061
682 HYPERCHOLESTEROLAEMIA 59 0.0061
683 ABSCESS 97 0.0061
684 GINGIVAL BLEEDING 83 0.0061
685 HYPERKALAEMIA 213 0.0061
686 COMA 289 0.0061
687 ARTHRITIS 477 0.0061
688 TOOTH EXTRACTION 75 0.0060
689 BLOOD TRIGLYCERIDES INCREASED 106 0.0060
690 LABORATORY TEST ABNORMAL 177 0.0060
691 DEPRESSED MOOD 316 0.0060
692 CONSTIPATION 1303 0.0060
693 AMNESIA 388 0.0060
694 MICTURITION URGENCY 68 0.0059
695 MEMORY IMPAIRMENT 816 0.0059
696 WOUND 166 0.0059
697 WOUND INFECTION 65 0.0059
698 MUSCULAR WEAKNESS 673 0.0059
699 THYROID DISORDER 91 0.0059
700 SCAR 101 0.0059
701 PLATELET COUNT DECREASED 628 0.0059
702 BIPOLAR DISORDER 64 0.0059
703 EATING DISORDER 125 0.0059
704 CANDIDA INFECTION 99 0.0059
705 GLOMERULAR FILTRATION RATE DECREASED 72 0.0059
706 CARPAL TUNNEL SYNDROME 82 0.0058
707 HERPES ZOSTER 336 0.0058
708 PANIC ATTACK 213 0.0058
709 DEVICE MALFUNCTION 407 0.0058
710 EJECTION FRACTION DECREASED 90 0.0058
711 THERAPY INTERRUPTED 413 0.0058
712 ARTHROPATHY 321 0.0058
713 WHITE BLOOD CELL COUNT INCREASED 221 0.0058
714 HAEMATURIA 197 0.0057
715 AGEUSIA 143 0.0057
716 EYE PAIN 322 0.0057
717 ARTHRALGIA 2372 0.0057
718 DEPRESSION 1297 0.0057
719 HAEMORRHAGE INTRACRANIAL 85 0.0057
720 OBSTRUCTIVE AIRWAYS DISORDER 63 0.0057
721 URINARY RETENTION 188 0.0056
722 SURGERY 330 0.0056
723 BLOOD PRESSURE INCREASED 857 0.0056
724 NEOPLASM MALIGNANT 374 0.0056
725 JOINT SWELLING 675 0.0056
726 GAIT DISTURBANCE 1069 0.0056
727 ERUCTATION 108 0.0056
728 ABDOMINAL PAIN 1294 0.0056
729 TYPE 2 DIABETES MELLITUS 187 0.0055
730 GASTRIC ULCER 105 0.0055
731 CAESAREAN SECTION 64 0.0055
732 DEVICE USE ERROR 190 0.0055
733 LIP SWELLING 182 0.0055
734 SARS-COV-2 TEST POSITIVE 72 0.0054
735 FREQUENT BOWEL MOVEMENTS 147 0.0054
736 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 261 0.0054
737 EYE SWELLING 201 0.0054
738 URINARY INCONTINENCE 160 0.0054
739 TREMOR 892 0.0054
740 OSTEOMYELITIS 97 0.0054
741 BLOOD PRESSURE SYSTOLIC INCREASED 104 0.0053
742 HEPATITIS C 64 0.0053
743 QUALITY OF LIFE DECREASED 71 0.0053
744 DYSSTASIA 154 0.0053
745 SCAB 60 0.0053
746 DEVICE BREAKAGE 213 0.0052
747 OSTEOARTHRITIS 222 0.0052
748 TASTE DISORDER 106 0.0052
749 ERYTHEMA 1073 0.0052
750 MUSCLE ATROPHY 66 0.0052
751 PULMONARY EMBOLISM 495 0.0052
752 HYPOAESTHESIA 779 0.0052
753 ACTIVITIES OF DAILY LIVING IMPAIRED 103 0.0052
754 LOWER RESPIRATORY TRACT INFECTION 235 0.0052
755 HEPATIC STEATOSIS 96 0.0051
756 MASS 72 0.0051
757 RASH PRURITIC 278 0.0051
758 MUSCULOSKELETAL DISORDER 97 0.0051
759 INFLUENZA LIKE ILLNESS 419 0.0051
760 NIGHT SWEATS 164 0.0051
761 DRUG ABUSE 421 0.0051
762 ACCIDENTAL OVERDOSE 185 0.0051
763 SOMNOLENCE 1017 0.0050
764 BONE PAIN 295 0.0050
765 INJECTION SITE IRRITATION 64 0.0050
766 DRUG ADMINISTRATION ERROR 154 0.0050
767 BALANCE DISORDER 433 0.0050
768 ENCEPHALOPATHY 123 0.0050
769 DISORIENTATION 198 0.0050
770 CONFUSIONAL STATE 806 0.0050
771 DEVICE USE ISSUE 87 0.0050
772 DRUG DISPENSING ERROR 76 0.0050
773 GAIT INABILITY 166 0.0050
774 VERTIGO 302 0.0050
775 BLOOD TEST ABNORMAL 69 0.0049
776 TOOTH DISORDER 109 0.0049
777 PERICARDITIS 82 0.0049
778 GENERALISED TONIC-CLONIC SEIZURE 80 0.0048
779 BURNING SENSATION 339 0.0048
780 COVID-19 848 0.0048
781 CEREBRAL INFARCTION 118 0.0048
782 SLEEP DISORDER 340 0.0048
783 MENTAL DISORDER 209 0.0048
784 DISCOMFORT 289 0.0047
785 HYPOPHAGIA 121 0.0047
786 THROAT TIGHTNESS 128 0.0047
787 EXTRA DOSE ADMINISTERED 191 0.0047
788 KNEE ARTHROPLASTY 99 0.0047
789 MUSCLE TWITCHING 108 0.0047
790 HYPOKINESIA 68 0.0047
791 NEUROPATHY PERIPHERAL 445 0.0047
792 FRACTURE 88 0.0046
793 ORAL PAIN 104 0.0046
794 PRODUCT ADMINISTRATION ERROR 93 0.0046
795 HYPOGLYCAEMIA 223 0.0046
796 OFF LABEL USE 3994 0.0046
797 LUNG NEOPLASM MALIGNANT 186 0.0045
798 HYPOMAGNESAEMIA 63 0.0045
799 BLOOD GLUCOSE DECREASED 217 0.0045
800 HYPOAESTHESIA ORAL 68 0.0045
801 DEMENTIA 126 0.0045
802 FUNGAL INFECTION 149 0.0045
803 FEAR 120 0.0045
804 INJURY 313 0.0044
805 CARDIOVASCULAR DISORDER 113 0.0044
806 PANCREATITIS 235 0.0044
807 SKIN DISORDER 148 0.0044
808 RASH MACULAR 155 0.0044
809 HYPONATRAEMIA 249 0.0044
810 LYMPHADENOPATHY 156 0.0044
811 PARAESTHESIA 691 0.0044
812 TOOTH LOSS 91 0.0044
813 BLOOD GLUCOSE ABNORMAL 81 0.0044
814 BLOOD CREATINE PHOSPHOKINASE INCREASED 126 0.0044
815 DEEP VEIN THROMBOSIS 284 0.0044
816 HEPATIC FUNCTION ABNORMAL 162 0.0043
817 DYSPHAGIA 412 0.0043
818 BONE DISORDER 79 0.0043
819 APATHY 63 0.0043
820 MANIA 71 0.0043
821 DYSARTHRIA 162 0.0043
822 SPEECH DISORDER 225 0.0043
823 PARANOIA 74 0.0043
824 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 302 0.0042
825 PANCREATITIS ACUTE 95 0.0042
826 FULL BLOOD COUNT DECREASED 85 0.0042
827 PREGNANCY 84 0.0042
828 SEIZURE 483 0.0042
829 PHOTOSENSITIVITY REACTION 69 0.0042
830 MULTIPLE FRACTURES 68 0.0041
831 ADVERSE EVENT 380 0.0041
832 TRANSAMINASES INCREASED 91 0.0041
833 DISTURBANCE IN ATTENTION 220 0.0041
834 MOOD ALTERED 111 0.0041
835 MIDDLE INSOMNIA 76 0.0041
836 THROMBOCYTOPENIA 455 0.0041
837 EMOTIONAL DISTRESS 492 0.0041
838 AGITATION 298 0.0041
839 MENTAL IMPAIRMENT 98 0.0040
840 BLISTER 227 0.0040
841 EXPOSURE DURING PREGNANCY 251 0.0040
842 LEUKOCYTOSIS 73 0.0040
843 ASTHMA 452 0.0040
844 INTENTIONAL OVERDOSE 256 0.0040
845 GLYCOSYLATED HAEMOGLOBIN INCREASED 100 0.0040
846 CHOLESTASIS 76 0.0040
847 BONE DENSITY DECREASED 124 0.0040
848 ABASIA 97 0.0039
849 HYPERSENSITIVITY 725 0.0039
850 COGNITIVE DISORDER 182 0.0039
851 MOBILITY DECREASED 280 0.0039
852 DISABILITY 77 0.0039
853 HEPATIC ENZYME INCREASED 263 0.0039
854 INCORRECT DOSE ADMINISTERED 880 0.0039
855 PRODUCT DOSE OMISSION IN ERROR 109 0.0038
856 IMPAIRED WORK ABILITY 82 0.0038
857 EMOTIONAL DISORDER 118 0.0038
858 LIVER INJURY 93 0.0038
859 RHABDOMYOLYSIS 158 0.0038
860 METABOLIC ACIDOSIS 121 0.0038
861 PRODUCT PRESCRIBING ERROR 90 0.0038
862 IRRITABLE BOWEL SYNDROME 81 0.0038
863 ABDOMINAL PAIN LOWER 95 0.0038
864 SKIN LESION 103 0.0038
865 SKIN IRRITATION 172 0.0038
866 RASH 1635 0.0037
867 APHASIA 113 0.0037
868 RESTLESSNESS 135 0.0037
869 SWOLLEN TONGUE 115 0.0037
870 PANCYTOPENIA 205 0.0037
871 THINKING ABNORMAL 68 0.0036
872 FOETAL EXPOSURE DURING PREGNANCY 295 0.0036
873 PRODUCT DISPENSING ERROR 79 0.0036
874 IMPAIRED HEALING 119 0.0036
875 PRODUCT DOSE OMISSION ISSUE 1065 0.0036
876 MEDICATION ERROR 201 0.0036
877 DYSGEUSIA 267 0.0036
878 PRODUCT SUBSTITUTION ISSUE 206 0.0036
879 C-REACTIVE PROTEIN INCREASED 130 0.0036
880 PRODUCT PHYSICAL ISSUE 72 0.0036
881 MENORRHAGIA 70 0.0036
882 ANGIOEDEMA 157 0.0035
883 EYE PRURITUS 119 0.0035
884 SKIN CANCER 76 0.0035
885 MUSCULOSKELETAL STIFFNESS 308 0.0035
886 IRRITABILITY 210 0.0035
887 FEMUR FRACTURE 108 0.0035
888 HYPERGLYCAEMIA 127 0.0035
889 JOINT STIFFNESS 91 0.0035
890 PRURITUS 1307 0.0034
891 CONVULSION 194 0.0034
892 RASH PAPULAR 76 0.0034
893 HEPATOTOXICITY 75 0.0034
894 DEPRESSED LEVEL OF CONSCIOUSNESS 133 0.0034
895 FIBROMYALGIA 81 0.0033
896 RASH ERYTHEMATOUS 158 0.0033
897 COLITIS 124 0.0033
898 INFLAMMATION 165 0.0032
899 PNEUMONITIS 87 0.0032
900 CONJUNCTIVITIS 59 0.0032
901 ABNORMAL BEHAVIOUR 126 0.0032
902 HALLUCINATION 238 0.0032
903 ALTERED STATE OF CONSCIOUSNESS 68 0.0031
904 ANGER 106 0.0031
905 ILL-DEFINED DISORDER 190 0.0031
906 AGGRESSION 155 0.0031
907 INCREASED APPETITE 59 0.0031
908 CRYING 112 0.0031
909 HYPOTHYROIDISM 98 0.0031
910 PRODUCT QUALITY ISSUE 416 0.0031
911 DERMATITIS 64 0.0031
912 ADVERSE DRUG REACTION 272 0.0030
913 HEPATITIS 77 0.0030
914 PAIN OF SKIN 81 0.0030
915 OVERDOSE 647 0.0030
916 GYNAECOMASTIA 92 0.0030
917 CONTRAINDICATED PRODUCT ADMINISTERED 90 0.0030
918 MOVEMENT DISORDER 95 0.0030
919 PROCEDURAL PAIN 81 0.0029
920 MATERNAL EXPOSURE DURING PREGNANCY 260 0.0029
921 BLOOD GLUCOSE INCREASED 548 0.0029
922 SUICIDAL IDEATION 266 0.0029
923 PRODUCT USE IN UNAPPROVED INDICATION 710 0.0029
924 RASH GENERALISED 74 0.0029
925 HALLUCINATION, VISUAL 60 0.0028
926 DRY EYE 140 0.0028
927 NIGHTMARE 96 0.0028
928 DELIRIUM 95 0.0027
929 TOXICITY TO VARIOUS AGENTS 461 0.0027
930 APPLICATION SITE PRURITUS 62 0.0027
931 MOOD SWINGS 87 0.0027
932 GLOSSODYNIA 61 0.0027
933 THERAPEUTIC RESPONSE DECREASED 162 0.0027
934 PHARMACEUTICAL PRODUCT COMPLAINT 69 0.0027
935 THERAPEUTIC PRODUCT EFFECT DECREASED 115 0.0026
936 WHITE BLOOD CELL COUNT DECREASED 275 0.0025
937 EYE IRRITATION 146 0.0025
938 ABNORMAL DREAMS 70 0.0025
939 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 455 0.0025
940 OSTEONECROSIS 82 0.0025
941 NERVOUS SYSTEM DISORDER 77 0.0025
942 DYSKINESIA 100 0.0025
943 DRY SKIN 328 0.0025
944 STOMATITIS 149 0.0025
945 MULTIPLE SCLEROSIS 117 0.0024
946 SUICIDE ATTEMPT 148 0.0024
947 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 70 0.0024
948 WRONG TECHNIQUE IN DRUG USAGE PROCESS 86 0.0024
949 INJECTION SITE ERYTHEMA 292 0.0024
950 URTICARIA 385 0.0023
951 INJECTION SITE PRURITUS 152 0.0023
952 APPLICATION SITE ERYTHEMA 59 0.0022
953 DRUG-INDUCED LIVER INJURY 69 0.0022
954 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 445 0.0022
955 EPILEPSY 65 0.0021
956 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 151 0.0021
957 PLASMA CELL MYELOMA 82 0.0021
958 INJECTION SITE RASH 63 0.0021
959 VAGINAL HAEMORRHAGE 89 0.0020
960 LACTIC ACIDOSIS 66 0.0020
961 COMPLETED SUICIDE 166 0.0020
962 SKIN EXFOLIATION 163 0.0019
963 INJECTION SITE HAEMORRHAGE 147 0.0018
964 UNDERDOSE 127 0.0017
965 RHEUMATOID ARTHRITIS 196 0.0017
966 ALOPECIA 339 0.0017
967 INJECTION SITE SWELLING 131 0.0017
968 DISEASE RECURRENCE 81 0.0017
969 COLITIS ULCERATIVE 75 0.0017
970 ANAPHYLACTIC REACTION 90 0.0016
971 ECZEMA 81 0.0015
972 INJECTION SITE PAIN 471 0.0015
973 WITHDRAWAL SYNDROME 63 0.0015
974 LEUKOPENIA 73 0.0015
975 DEVICE DIFFICULT TO USE 94 0.0014
976 DRUG WITHDRAWAL SYNDROME 123 0.0014
977 TREATMENT FAILURE 115 0.0014
978 NO ADVERSE EVENT 246 0.0014
979 BLADDER CANCER 79 0.0013
980 SKIN BURNING SENSATION 96 0.0013
981 INFUSION RELATED REACTION 88 0.0013
982 DRUG DEPENDENCE 204 0.0013
983 INJECTION SITE REACTION 83 0.0012
984 FEBRILE NEUTROPENIA 79 0.0012
985 MULTIPLE SCLEROSIS RELAPSE 81 0.0012
986 ACCIDENTAL EXPOSURE TO PRODUCT 114 0.0011
987 PSORIASIS 136 0.0010
988 BREAST CANCER 88 0.0009
989 INJECTION SITE BRUISING 74 0.0009
990 NEUTROPENIA 120 0.0009
991 ACNE 59 0.0008